Genomic Health (GHDX) Inactive 10-Q2007 Q1 Quarterly report

Filed: 10 May 07, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Good

New words: accommodate, AG, amended, amendment, amortization, amortized, assay, AviaraDX, bad, Barack, billable, CIGNA, classification, Code, condensed, Criterion, deem, Department, deposit, desirable, differentiation, disclaim, discourage, disposition, document, doubtful, Edward, enacted, ER, estrogen, Exagen, examination, exhausted, fifty, GAAP, goal, Horizon, House, Humana, incidence, inhibitor, Jersey, Kennedy, language, largest, LDT, liquidity, matrix, Medicine, Midwest, multiplying, nearby, network, ninety, node, NOL, notifying, Notwithstanding, Obama, OncotypeDXTM, perception, Personalized, pipeline, PR, previously, progesterone, protein, ranging, receptor, refine, reportedly, resolution, Revitalization, ScoreTM, Secretary, Senate, Senator, showing, single, Southeast, substantive, symposia, taxable, thirty, unfavorable, voluntarily, withdraw

Removed: acceleration, activity, adjustment, analyst, Antonio, APB, automatic, automatically, bearing, brew, cancelable, colorectal, comprised, concurrent, conditional, consisted, consulting, converted, convertible, correlation, death, deducting, deferred, dialogue, director, disability, disproportionate, distributor, earlier, earliest, earning, effected, England, equal, Erbitux, exercisability, exercisable, fluctuate, forma, fourth, fractional, fresh, frozen, governed, Harvard, Highmark, home, identified, Incyte, initially, initiation, intention, inThe, invested, investigate, involved, Journal, led, lieu, lymph, Medicineand, member, metastatic, Miami, milestone, monthly, Nasdaq, nonstatutory, offered, Opinion, optionee, organized, Pfizer, Pilgrim, placement, planned, platform, Premera, pricing, pro, pursuant, rata, rent, reserved, response, restated, retirement, retroactive, retroactively, retrospective, revalue, reversed, SAR, seasonality, SEC, select, separate, spending, split, stream, Symposium, Taxotere, timeline, travel, underlying, underwriting, unit, unrelated, upgrading, weighted

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

GHDX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

STATEMENT OF CHIEF EXECUTIVE OFFICER
UNDER 18 U.S.C. § 1350

I, G. Bradley Cole, the chief financial officer of Genomic Health, Inc. (the “Company”), certify for the purposes of section 1350 of chapter 63 of title 18 of the United States Code that, to the best of my knowledge,

(i) the Quarterly Report of the Company on Form 10-Q for the period ended March 31, 2007 (the “Report”) fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934, and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: May 10, 2007	/s/ G. Bradley Cole
	G. Bradley Cole
	Chief Financial Officer